Biopharmaceutical Company Moleac has announced the launch in France and Belgium of NurAiD II. NurAiD II is a natural health supplement engineered to stimulate neuroplasticity and recovery.

SINGAPORE, June 27, 2011 /PRNewswire-Asia/ -- In June 2011, " Neuropharmacology " published a paper establishing NeuroAiD's reparative effects on global cerebral ischemia. Global cerebral ischemia is subsequent to cardiac arrest, reversible severe hypotension or other situations depriving the brain of oxygen and glucose. It results in residual neurologic deficits, ranging ...

SINGAPORE , March 13 /PRNewswire-Asia/ -- Moleac Pte Ltd has been granted the Emerging Company of the Year 2010 Award by BioSpectrum, the leading integrated media platform for the Life Science Industry in the Asia Pacific . This award recognizes Moleac's innovative business model; its contribution to ...

The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting pharmacological data establishing NeuroAiD (MLC 601) protective effects on neuronal and brain injuries as well as its effectiveness in neurological functions recovery. The French research team was led by Prof. Michel Lazdunski, world-renowned specialist ...

SINGAPORE , Feb. 11 /PRNewswire-Asia/ -- The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting pharmacological data establishing NeuroAiD (MLC 601) protective effects on neuronal and brain injuries as well as its effectiveness in neurological functions recovery....